New drug ZW191 targets Hard-to-Treat cancers in early trial
Disease control
Ongoing
This early-stage study tests a new drug called ZW191 in about 145 people with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancers. The drug is designed to deliver a cancer-killing agent directly to cells that have a specific marker (folate recep…
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC